updat number caution still warrant
view even iqo approv
leav ep larg unchang pt usd remain cautiou
altria continu believ increasingli pressur market
shift reduc risk product furthermor perhap influenc
build pressur believ overpaid juul could gone
attract asset cannabi space crono
tweak estim slightli follow recent result see adj ep
usd vs usd previous con usd guidanc usd
see sale growth vs previous ebit growth vs margin
vs ep growth vs guidanc pt
continu see altria pressur rrp world
time express concern altria basi feel could
struggl rrp world larg due cigarett share give higher
hurdl argu would difficult take share rrp
wash face vapour proposit inferior iqo still
approv smokeless lack competit snu especi given
bat like get mrtp camel absenc nicotin pouch bat
swedish match could weigh
assum recent action solv potenti headwind
obviou push back would number area
address strengthen vapour posit juul invest
ioq approv ad anoth avenu growth
crono cannabi stake urg caution juul think paid much
overestim intern opportun plu regulatori risk remain
 possibl fda action continu lawsuit
compani anoth one north carolina announc yesterday iqo
rememb first altria would need take fair share off-set
licens fee pm assum cost plu current could
second assum altria segment bat
compet approv product theori could greater appeal
smoker replic smoke close conced risk
around consist perform would give iqo advantag
bat push date possibl reason may put
limit invest behind could simpli due less favour econom
crono think attract asset cannabi space least
money paid final thing add bottom line contribut
asset like minim near term
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
continu share pressur marlboro
minim incom invest near term
iqo get approv second half
year earliest
mrtp approv bat snu trigger concern around
outlook snuff
marlboro share pressur revers begin
iqo get approv immin mean get market
roughli time bat heat tobacco product
bat get mrtp approv snu product
guidanc ahead market expect
marlboro share pressur continu get notabl
wors compani respond implement aggress
iqo get approv
fda rule vapour pod need remov
market subject pmta
market share pressur marlboro build
compani trail bat market heat offer
possibl addit pressur smokeless think altria
find increasingli difficult maintain share
given build pressur announc deal make sens
logic think price paid time mean valu
destruct possibl furthermor two thing
realli appeal investor earn visibl
littl debt less
monthli us cigarett vapour nielsen updat
show share pressur categori
details/data point around iqo roll
like mrtp approv bat snu like
trigger concern around outlook snuff
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
exc impair exit impair impair leas corpor kraft pmi transact asset impair exit earli extinguish earn incom control ratio dp distribut basic dilut exhibit balanc sheet
pleas see import disclosur inform page report
incom current intang consum servic settlement current current incom consum servic non control paid comprehens control liabil stockhold exhibit flow
pleas see import disclosur inform page report
operationsnet impair exit sab sab cash consum provid oper investinginvest busi sale fix asset use invest financingdividend buy use financ debt debt equiti research
inc hold compani engag product market tobacco product oper
follow segment smokeabl product smokeless product wine smokeabl product segment compris
cigarett manufactur sold pm usa machine-mad larg cigar pipe tobacco manufactur sold
middleton smokeless product segment manufactur sold behalf usstc pm usa wine segment
produc washington state wine primarili chateau michel columbia crest own wineri distribut wine
sever wine region compani held around cigarett market share us compani
found headquart richmond va
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi downsid risk discount fda vapour intervent
unfavour iqo term menthol ban upsid risk marlboro begin gain share juul growth continu
trajectori us intern expans success crono global winner cannabi
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi risk subdu rrp non-deliveri deal synergi
valu compani cannabi sector year dcf driven market share assumpt differ geographi
product segment upsid risk legalis disrupt industri
valuat deriv two separ yr dcf one rrp vapour heat second rest busi
larg cigarett neg tg appli non-rrp busi risk combust pressur rrp contribut stall
valu swedish match sum part use year dcf differ busi segment individu risk
competit pressur scandi intensifi regul significantli impact cigar volum traction stall us snus/nic pouch
owen bennett cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli
indirectli relat specif recommend view express research report
ryan tomkin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
registr non-u analyst owen bennett cfa employ jefferi intern limit non-u affili
jefferi llc registered/qualifi research analyst finra analyst may associ person
jefferi llc finra member firm therefor may subject finra rule restrict commun
subject compani public appear trade secur held research analyst
registr non-u analyst ryan tomkin employ jefferi intern limit non-u affili jefferi llc
registered/qualifi research analyst finra analyst may associ person jefferi llc
finra member firm therefor may subject finra rule restrict commun subject
compani public appear trade secur held research analyst
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom
seek updat research appropri variou regul may prevent us asid certain industri
pleas see import disclosur inform page report
